Prevalence of anxiety and depression among pregnant women during the COVID-19 pandemic: a systematic review and meta-analysis

DOI: https://doi.org/10.21203/rs.3.rs-87129/v1

Abstract

Background COVID-19 has become a global pandemic. Its occurrence has substantially affected the psychological condition of pregnant women. The purpose of this study is to learn about the incidence of anxiety and depression among pregnant women during the pandemic, and to conduct a meta-analysis of the existing research.

Methods PubMed, Web of Science and EMBASE were searched without a lower time limit and up to August 13, 2020. The incidences of anxiety and depression among pregnant women were synthesized and discussed.

Results The prevalence of anxiety in 8 studies with a total sample size of 7493 individuals was 43% (95% confidence interval: 0.28-0.58), and the prevalence of depression in 7 studies with a sample size of 6116 people was 32% (95% confidence interval: 0.26-0.37). Significant heterogeneity was detected across studies of these incidence estimates. Subgroup analysis included the economic status to explore the sources of heterogeneity, and Egger’s test was conducted to examine the publication bias.

Conclusions Since significant heterogeneity has been detected in studies of anxiety and depression, we must interpret the results with caution. As the COVID-19 pandemic will not end in a short time, corresponding psychological interventions must be implemented to address the mental health of pregnant women.

Introduction

COVID-19 has been a public health emergency since it was discovered in Wuhan in December 2019. In March 2020, the COVID-19 epidemic was classified as a global pandemic by WHO.

 

As the first country with a COVID-19 outbreak, China began to be closed quickly. Patients with a confirmed and suspected diagnosis were isolated in the hospital, and the uninfected individuals were isolated at home. Because this measure was the most concise and effective, other countries and regions affected by the pandemic also began to shut down.

 

Most of the anxiety and fear comes from the unknown of the COVID-19 and its high infectivity. Moreover, there are no completely effective preventive or treatment measures. For pregnant women, they also worry about whether the COVID-19 will affect the fetus. Psychological problems such as anxiety and depression during pregnancy not only affect pregnant women themselves but also fetuses and newborns, causing conditions such as preterm birth, low birth weight, higher cortisol levels, and lower DA and 5-HT levels, among others (Diego et al. 2004; Tiffany Field et al. 2004; Dunkel Schetter and Tanner 2012)。

 

A study presented that the anxiety of pregnant women was higher than that before the outbreak during the SARS pandemic in 2003, while the depression was not significantly changed (Lee et al. 2006). However, due to the lack of research on the psychology of pregnant women during SARS and other infectious diseases such as MERS and H7N9, we cannot understand the psychological effect of the outbreak of infectious diseases on pregnant women fully. Previous epidemics of infectious diseases did not last too long, but the COVID-19 epidemic has not stopped until now. This pandemic is more serious than any previous one. So, we are curious about the impact of the COVID-19 on the anxiety and depression of pregnant women.

 

The incidences of anxiety and depression in the perinatal period are 22.9% (Dennis, Falah-Hassani, and Shiri 2017) and 11.9% (Woody et al. 2017). In theory, the incidence of these disorders will increase during an epidemic. One study has reported that pregnant women during covid-19 are more likely to have anxiety and depression than before (OR = 1.94, χ2 = 10.05) (Berthelot et al. 2020). However, another study showed that the incidence of depression during the outbreak did not change significantly compared with that before the outbreak (OR = 1, 95% CI 0.52-1.93) (Sade et al. 2020). Statistical analyses are still lacking due to the inconsistency of existing research results. The purpose of this study is to systematically review and analyze the incidence rates of anxiety and depression in pregnant women during the new COVID-19 pandemic to guide the implementation of better psychological interventions.

Methods

Search Strategy

We systematically searched the literature in the PubMed, Web of Science and EMBASE databases. The retrieval period did not have a lower time limit and the upper limit was August 13, 2020. The search terms Coronavirus, COVID-19, 2019-ncov, SARS-cov-2, Anxiety, Depression, and all the possible combinations of these keywords were used to identify relevant articles.

 

The following keywords were used for the search: (COVID-19 OR 2019 novel coronavirus disease OR COVID19 OR COVID-19 pandemic OR SARS-CoV-2 infection OR COVID-19 virus disease OR 2019 novel coronavirus infection OR 2019-nCoV infection OR coronavirus disease 2019 OR coronavirus disease-19 OR 2019-nCoV disease OR COVID-19 virus infection) AND (Pregnant Women OR Pregnant Woman OR Woman, Pregnant OR Women, Pregnant OR Pregnancy OR Pregnancies OR Gestation) AND (depression OR depressive OR Melancholia OR Melancholias OR Anxiety OR Hypervigilance OR Nervousness OR Social Anxiety OR Anxieties, Social OR Anxiety, Social OR Social Anxieties).

 

The literature search had no language restrictions.

 

Selection Criteria

The inclusion criteria were 1. case reports, case series and observational studies of pregnant women with COVID-19; 2. studies that examined the prevalence of anxiety and depression; and 3. the full text was available. The exclusion criteria were 1. unrelated research articles; 2. article types such as authors’ replies, reviews, and guidelines; 3. duplicate articles; 4. articles with incomplete or missing data; and 5. articles where the full text was unavailable.

 

Quality Assessment

Two reviewers independently reviewed each included article. The items on the checklist included the article title, first author’s name, year of publication, country of study, sample size, assessment method, type of study, and the prevalence rates of anxiety and depression. When the reviewers’ opinions were inconsistent, they sought the opinion of the third reviewer or negotiated a solution.

 

Statistical Analysis

A random-effect model was used to estimate the pooled proportion of anxiety and depression. Statistical heterogeneity was considered present when p < 0.1 or I2 > 50%. Publication bias was evaluated visually by constructing funnel plots and considered significant when p < 0.05 according to Egger’s test. STATA 14.0 software (Stata Corporation, College Station, TX, USA) was also used to conduct different analyses and all statistical tests.

 

Results

Search Results

A total of 129 articles were obtained using the search strategy. Among them, 63 articles were excluded because of duplication. After screening the titles and abstracts, 50 articles were excluded because of irrelevant contents or because they met the exclusion criteria. After screening the full-text of the remaining 16 articles, five were excluded because they did not contain the data we aimed to analyze. Finally, this study included 11 cross-sectional studies. The study selection process is illustrated in Figure 1.

 

Study Characteristics

The summary characteristics of the included 11 studies were presented in Table 1. All of the included studies were cross-sectional studies and published in 2020. In terms of research region, 3 studies were conducted in China, 2 in Italy, 1 in USA, 1 in Belgium, 1 in Turkey, 1 in Canada, 1 in Sri Lanka and 1 in Israel. The studies were based on 45 to 1947 pregnant women, comprised a total sample size of 7493 on anxiety and 6116 on depression. 3 studies used Generalized Anxiety Disorder (GAD-7), 1 study used the Patient-Reported Outcomes Measurement Information System (PROMIS), 1 study used Hamilton Depression Rating Scale (HDRS), 1 study used Self-Rating Anxiety Scale (SAS), and 2 studies used the State-Trait Anxiety Inventory (STAI) to assess anxiety among pregnant women. 1 study used Patient Health Questionnaire (PHQ9), 1 study used HDRS, 1 study used the Edinburgh Depression Scale (EDS), and 4 studies used the Edinburgh Postnatal Depression Scale (EPDS) to assess depression.

 

Since the included studies were all cross-sectional studies, the Combie cross-sectional study evaluation tool was used to evaluate the included studies (Crombie 1996). An item would receive a score of ‘0’ if the answer was ‘NO’, ‘0.5’ for ‘UNCLEAR’, and ‘1’ for an answer of ‘YES’. The quality of the articles was assessed as follows: low quality = 0–3.5; moderate quality = 4.0–5.5; and high quality = 6.0–7.0. Based on it, 1 study was of high methodological quality and 10 studies were of moderate methodological quality.

 

Some studies did not clearly define anxiety and depression, but divided these conditions into three categories: mild, moderate, and severe. In the statistical analysis, we included the patients with moderate and severe anxiety and depression.

 

Overall Prevalence of Anxiety

The prevalence of anxiety within the population reported in eight studies with 7493 subjects ranged from 3% to 82% (Figure 2). Meta-analytic pooling of these rates generated an overall prevalence of 43% (95% CI: 0.28–0.58, p=0.000, I2=99.7%), which was calculated using the random-effects model (p<0.05), with significant between-study heterogeneity observed.

 

Because the medical quality and scientific research level of a region are related to its economic status, we performed a subgroup analysis (Figure 3). The summarized proportion of pregnant women with anxiety in developed countries was 49% (95% CI: 0.28-0.71), while the value in developing countries was 33% (95% CI: 0.07-0.60).

 

To examine publication bias in the collected articles, Egger’s test was conducted to determine publication bias in terms of the prevalence of anxiety in the included articles(p=0.010) (Figure 4). Publication bias was observed.

 

Overall Prevalence of Depression

The prevalence of depression within the population reported in seven studies with 6116 subjects ranged from 19% to 64% (Figure 5). Meta-analytic pooling of these rates generated an overall prevalence of 32% (95% CI: 0.26-0.37, p=0.000, I2=94.6%), which was calculated using the random-effects model (p<0.05). Significant between-study heterogeneity was observed.

 

A subgroup analysis was performed (Figure 6). The summarized proportion of pregnant women with depression in developed countries was 29% (95% CI: 0.20-0.39), while the proportion in developing countries was 35% (95% CI: 0.25-0.45). Egger’s test of the prevalence of depression was performed (p=0.567) (Figure 7) and revealed that publication bias did not exist.

Discussion

The high heterogeneity was discovered in the present study. Therefore, we performed subgroup analysis. However, the heterogeneity of each group did not change significantly. The possible reasons must be considered with caution. The sample sizes of the included articles vary greatly. The effectiveness of different scales for screening anxiety and depression also differs. Since the present study is a meta-analysis of a single group without control groups, the heterogeneity of the meta-analysis may be significant and high. However, due to the relatively small number of studies included, we did not conduct a sensitivity analysis and meta-regression analysis to exclude some studies.

 

Publication bias was observed in the meta-analysis of anxiety. Due to the pandemic, the speed of review of articles will be affected. The studies may be under review or not yet published. The countries in which the included studies were conducted are mainly located in China, North America and Europe, but the new disease is a global pandemic. Relevant research or investigations may not have been conducted in other areas yet. Alternatively, the published articles may not have been included in the databases. All of these factors may lead to publication bias.

 

This study aims to estimate the incidence rates of anxiety and depression among pregnant women worldwide. According to the results, we can provide information about the corresponding psychological interventions to implement during pregnancy. Therefore, despite the presence of publication bias and high heterogeneity, this study still has some reference value.

 

The psychological problems of pregnant women are mainly due to the isolation caused by the pandemic. These women experience loneliness because of reduced social interactions and anxiety caused by trivial matters during pregnancy. During this period, the husband's company is particularly important. According to some studies, when the husband is not around, the incidences of psychological problems such as fear, depression and anxiety, in pregnant women will increase; however, if the husband also has corresponding psychological problems, the couple will interact with each other(Ahorsu et al. 2020). Therefore, in addition to the pregnant women themselves, their families also require corresponding psychological support.

 

Due to isolation alone at home, most of the studies included in the study were conducted using means of online questionnaires. Many people spend most of their time browsing the Internet to alleviate their anxiety and loneliness. News about COVID-19 will increase anxiety(WHO 2020). A wide variety of information about COVID-19 is available on the Internet. Most of the information is negative. Therefore, a closer focus on the information on the pandemic available on the Internet will lead to increased anxiety (Moghanibashi-Mansourieh 2020). Exaggeration and false information about the new pandemic will increase people's anxiety, while positive news about disease cures and vaccine development will reduce psychological problems. Therefore, during the pandemic, appropriate information should be selected, and communication and relaxation through interaction with the social network are recommended.

 

In the present study, we conducted a subgroup analysis based on the economic status of the source regions. Due to the limited number of articles, this parameter did not affect the overall heterogeneity. In addition to people from different regions, the risk of psychological problems will also be significantly different among people in the same area, because of the differences in occupation, income, education background and cognitive level. A study has shown that, compared to people with a master's degree or higher, those with a bachelor's degree group had a depression risk of 0.39 (95% CI 0.17-0.87). Compared with professionals, industrial service workers and other staff had a depression risk of 0.31 (95% CI 0.15-0.65) and 0.38 (95% CI 0.15-0.93) respectively (Wang et al. 2020). The potential explanation for this finding is that people with a higher income and cognitive level may pay closer attention to their mental health. Pregnant women have a similar focus on their mental health. Therefore, we closely monitor the psychological status of pregnant women with different incomes and cognitive levels, and provide different interventions based on their differences and specific conditions.

 

In addition, no difference in the levels of depression and anxiety were reported between pregnant women who were positive for COVID-19 and women without the infection in a recent study (Kotabagi et al. 2020). However, due to the small number of included samples, the research results should not be generalized and are not representative. However, because the COVID-19-positive mothers are isolated in a hospital, they will have greater access to the corresponding psychological interventions.

Conclusion

In a few months, COVID-19 has become a global pandemic. It not only substantially affects people's physical health but also exerts a certain effect on people's psychological condition, particularly pregnant individuals with greater emotional sensitivity. An understanding of the incidence rates of anxiety and depression among pregnant women is important to guide the implementation of psychological interventions prior to the occurrence of these disorders.

Declarations

Authors’ contributions

H.Y and Y.G conducted the literature search and selected studies. Q.X and Y.Y assessed the methodological quality of the studies and extracted data. J.Z conceived and planned the review, assessed the methodological quality of the studies, verified the data, and drafted and revised the manuscript. R.Z provided methodological advice, content expertise, and revised the manuscript. All authors contributed to writing the protocol. All authors read and approved the final manuscript.

 

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author upon reasonable request.

 

Ethics approval and consent to participate

Not applicable.

 

Competing interests

The authors declare that they have no competing interests.

 

Funding

This work was supported by the National Natural Science Foundation of China (No. 81571465, No. 81871175). The mentioned foundation had no rule in the study design, data analysis, drafting the manuscript, or decision to submit this article for publication.

References

Ahorsu, Daniel Kwasi, Vida Imani, Chung-Ying Lin, Toomas Timpka, Anders Brostrom, John A. Updegraff, Kristofer Arestedt, Mark D. Griffiths, and Amir H. Pakpour. 2020. 'Associations Between Fear of COVID-19, Mental Health, and Preventive Behaviours Across Pregnant Women and Husbands: An Actor-Partner Interdependence Modelling', International Journal of Mental Health and Addiction.

Berthelot, Nicolas, Roxanne Lemieux, Julia Garon-Bissonnette, Christine Drouin-Maziade, Elodie Martel, and Michel Maziade. 2020. 'Uptrend in distress and psychiatric symptomatology in pregnant women during the coronavirus disease 2019 pandemic', Acta Obstetricia Et Gynecologica Scandinavica, 99: 848-55.

Ceulemans, Michael, Titia Hompes, and Veerle Foulon. 2020. 'Mental health status of pregnant and breastfeeding women during the COVID-19 pandemic: A call for action', International Journal of Gynecology & Obstetrics.

Crombie, Iain. 1996. Pocket Guide to Critical Appraisal (BMJ publishing group: London, England).

Dennis, C. L., K. Falah-Hassani, and R. Shiri. 2017. 'Prevalence of antenatal and postnatal anxiety: systematic review and meta-analysis', Br J Psychiatry, 210: 315-23.

Diego, M. A., T. Field, M. Hernandez-Reif, C. Cullen, S. Schanberg, and C. Kuhn. 2004. 'Prepartum, postpartum, and chronic depression effects on newborns', Psychiatry, 67: 63-80.

Dunkel Schetter, C., and L. Tanner. 2012. 'Anxiety, depression and stress in pregnancy: implications for mothers, children, research, and practice', Curr Opin Psychiatry, 25: 141-8.

Durankuş, F., and E. Aksu. 2020. 'Effects of the COVID-19 pandemic on anxiety and depressive symptoms in pregnant women: a preliminary study', J Matern Fetal Neonatal Med: 1-7.

Kotabagi, P., M. Nauta, L. Fortune, and W. Yoong. 2020. 'COVID-19 positive mothers are not more anxious or depressed than non COVID pregnant women during the pandemic: A pilot case-control comparison', Eur J Obstet Gynecol Reprod Biol.

Lebel, C., A. MacKinnon, M. Bagshawe, L. Tomfohr-Madsen, and G. Giesbrecht. 2020. 'Elevated depression and anxiety symptoms among pregnant individuals during the COVID-19 pandemic', J Affect Disord, 277: 5-13.

Lee, D. T., D. Sahota, T. N. Leung, A. S. Yip, F. F. Lee, and T. K. Chung. 2006. 'Psychological responses of pregnant women to an infectious outbreak: a case-control study of the 2003 SARS outbreak in Hong Kong', J Psychosom Res, 61: 707-13.

Li, X., P. Lu, L. Hu, T. Huang, and L. Lu. 2020. 'Factors Associated with Mental Health Results among Workers with Income Losses Exposed to COVID-19 in China', Int J Environ Res Public Health, 17.

Liu, X., M. Chen, Y. Wang, L. Sun, J. Zhang, Y. Shi, J. Wang, H. Zhang, G. Sun, P. N. Baker, X. Luo, and H. Qi. 2020. 'Prenatal anxiety and obstetric decisions among pregnant women in Wuhan and Chongqing during the COVID-19 outbreak: a cross-sectional study', Bjog.

Mappa, I., F. A. Distefano, and G. Rizzo. 2020. 'Effects of coronavirus 19 pandemic on maternal anxiety during pregnancy: a prospectic observational study', J Perinat Med, 48: 545-50.

Moghanibashi-Mansourieh, A. 2020. 'Assessing the anxiety level of Iranian general population during COVID-19 outbreak', Asian J Psychiatr, 51: 102076.

Patabendige, M., M. M. Gamage, M. Weerasinghe, and A. Jayawardane. 2020. 'Psychological impact of the COVID-19 pandemic among pregnant women in Sri Lanka', Int J Gynaecol Obstet.

Preis, H., B. Mahaffey, C. Heiselman, and M. Lobel. 2020. 'Pandemic-related pregnancy stress and anxiety among women pregnant during the coronavirus disease 2019 pandemic', American Journal of Obstetrics and Gynecology MFM, (no pagination).

Saccone, G., A. Florio, F. Aiello, R. Venturella, M. C. De Angelis, M. Locci, G. Bifulco, F. Zullo, and A. Di Spiezio Sardo. 2020. 'Psychological impact of coronavirus disease 2019 in pregnant women', Am J Obstet Gynecol, 223: 293-95.

Sade, S., E. Sheiner, T. Wainstock, N. Hermon, S. Yaniv Salem, T. Kosef, T. Lanxner Battat, S. Oron, and G. Pariente. 2020. 'Risk for Depressive Symptoms among Hospitalized Women in High-Risk Pregnancy Units during the COVID-19 Pandemic', J Clin Med, 9.

Tiffany Field, Miguel Diego, John Dieter, Maria Hernandez-Reif, Saul Schanberg, Cynthia Kuhn, Regina Yando, and Debra Bendell. 2004. 'Prenatal depression effects on the fetus and the newborn', Infant Behavior and Development, 27: 216-29.

Wang, Y., Y. Di, J. Ye, and W. Wei. 2020. 'Study on the public psychological states and its related factors during the outbreak of coronavirus disease 2019 (COVID-19) in some regions of China', Psychol Health Med: 1-10.

WHO. 2020. 'Mental health and psychosocial considerations during the COVID-19 outbreak,18 March 2020', Geneva: World Health Organization: 6.

Woody, C. A., A. J. Ferrari, D. J. Siskind, H. A. Whiteford, and M. G. Harris. 2017. 'A systematic review and meta-regression of the prevalence and incidence of perinatal depression', J Affect Disord, 219: 86-92.

Wu, Y., C. Zhang, H. Liu, C. Duan, C. Li, J. Fan, H. Li, L. Chen, H. Xu, X. Li, Y. Guo, Y. Wang, X. Li, J. Li, T. Zhang, Y. You, H. Li, S. Yang, X. Tao, Y. Xu, H. Lao, M. Wen, Y. Zhou, J. Wang, Y. Chen, D. Meng, J. Zhai, Y. Ye, Q. Zhong, X. Yang, D. Zhang, J. Zhang, X. Wu, W. Chen, C. L. Dennis, and H. F. Huang. 2020. 'Perinatal depressive and anxiety symptoms of pregnant women during the coronavirus disease 2019 outbreak in China', Am J Obstet Gynecol, 223: 240.e1-40.e9.

 

Table

First author

Study date
(year, month, day)

Region

Study design

Survey method

Study population

Patients (No.)

Assessment tools

Quality score

Anxiety

Depression

Anxiety

Depression

Ceulemans, M. (Ceulemans, Hompes, and Foulon 2020)

NA

Belgium

cross-sectional

online questionnaire

2421

327

612

GAD-7

EDS

5.5

Durankuş, F. (Durankuş and Aksu 2020)

NA

Turkey

cross-sectional

online questionnaire

260

NA

92

NA

EPDS

5.5

Lebel, C. (Lebel et al. 2020)

2020.4.5-2020.4.20

Canada

cross-sectional

Semi-structured interview

1764

813

653

PROMIS

EPDS

6

Li, X. (Li et al. 2020)

2020.4.25-2020.5.9

China

cross-sectional

online survey and face-to-face interviews

45

37

29

GAD-7

PHQ-9

5.5

Liu, X. (Liu et al. 2020)

2020.2.3-2020.2.9

China

cross-sectional

online questionnaire

1947

64

NA

SAS

NA

5.5

Mappa, I. (Mappa, Distefano, and Rizzo 2020)

2020.3.9-2020.3.12

Italy

cross-sectional

online semi-structured questionnaire

178

137

NA

STAI

NA

5.5

Patabendige, M. (Patabendige et al. 2020)

2020.4.27-2020.5.20

Sri Lanka

cross-sectional

face-to-face questionnaire

257

45

50

HADS

HADS

5.5

Preis, H. (Preis et al. 2020)

-2020.4

USA

cross-sectional

online questionnaire

788

341

NA

GAD-7

NA

5.5

Saccone, G. (Saccone et al. 2020)

2020.3.15-2020.4.1

Italy

cross-sectional

NA

100

68

NA

STAI

NA

5.5

Sade, S. (Sade et al. 2020)

2020.3.19-2020.5.26

Israel

cross-sectional

face-to-face questionnaire

84

NA

21

NA

EPDS

5.5

Wu, Y. (Wu et al. 2020)

2020.1.1-2020.2.9

China

cross-sectional

face-to-face questionnaire

1285

NA

372

NA

EPDS

5.5

Table 1 Characteristics of the studies included in the meta-analysis